Company / Working Capital per Share
ROCKET PHARMACEUTICALS, INC. Working Capital per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$1.53
FY2025
5-year range
$1.53 / $6.06
FY2021-FY2025
Trend
-59.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has declined for 5 consecutive years, from $8.30 in FY2020 to $1.53 in FY2025.
Based on SEC 10-K filings.
1.53 in FY2025 with a 5-year CAGR of -28.7%.
Declined from $4.17 to $1.53 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -32.8%
- 5-Year CAGR
- -28.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- ROCKET PHARMACEUTICALS, INC.'s working capital per share has declined for 5 consecutive years.
- In FY2025, working capital per share decreased 59.2% year-over-year.
- Peak working capital per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.68 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.53 | -59.2% |
| FY2024 | $3.74 | -10.3% |
| FY2023 | $4.17 | -17.3% |
| FY2022 | $5.04 | -16.9% |
| FY2021 | $6.06 | -27.0% |
| FY2020 | $8.30 | +29.5% |
| FY2019 | $6.41 | -77.5% |
| FY2018 | $28.51 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026